http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014139974-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-75
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-75
filingDate 2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2014139974-A
titleOfInvention IMPROVED PROCESS OF OBTAINING FIBRINOGEN AND FIBRINOGEN OBTAINED IN THIS WAY
abstract 1. A method of purifying a source containing fibrinogen by precipitating fibrinogen from a solution containing fibrinogen in the presence of one or more chelating agents (a) and removing the supernatant from the fibrinogen paste, characterized in that the fibrinogen is extracted from the paste forming a liquid fraction containing fibrinogen and an undissolved residue that separates from the liquid in the absence of the addition of one or more protease inhibitors (a). 2. The method of claim 1, wherein the one or more protease inhibitors (a) are selected from C1 protease inhibitors, trypsin inhibitors, thrombin inhibitors, antithrombin III (AT-III), cofactor heparin II, aprotinin, pepstatin, leipeptin and epsilon aminocaproic acid. 3. The method according to one of paragraphs. 1 or 2, where one or more of the chelating agents (a) is a Ca2 + chelating agent selected from 1,2-bis (o-amino) ethane-Ν, Ν, Ν ', Ν'-tetraacetic acid (BAPTA) diethylenetriaminepentaacetic acid (DTPA), ethylenediaminetetraacetic acid (EDTA), ethylene glycol tetraacetic acid (EGTA) and nitrilotriacetic acid (NTA). 4. The method according to one of paragraphs. 1 or 2, where the concentration of the chelating agent is in the range of 3 mM to 100 mM. 5. The method according to one of paragraphs. 1 or 2, where the concentration of the chelating agent is in the range of 5 mM to 50 mM. 6. The method according to one of paragraphs. 1 or 2, where the concentration of the chelating agent is in the range of 5 mM to 20 mM. 7. The method according to one of paragraphs. 1 or 2, where fibrinogen is precipitated in the temperature range from 4.1 ° C to 40 ° C, in particular in the range from 5 ° C to 37 ° C, using a precipitating agent, which, in particular, is selected from the group consisting of amino acids, polyethylene glycol or salts in high concentrations or combinations thereof, where the salt contains one
priorityDate 2012-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID304917
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41361
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5478883
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552883
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6207
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01008
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8758
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525332
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32261
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R5A3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11905
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727

Total number of triples: 56.